These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 11490304)

  • 1. Frequently deleted loci on chromosome 9 may harbor several tumor suppressor genes in human renal cell carcinoma.
    Grady B; Goharderakhshan R; Chang J; Ribeiro-Filho LA; Perinchery G; Franks J; Presti J; Carroll P; Dahiya R
    J Urol; 2001 Sep; 166(3):1088-92. PubMed ID: 11490304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Loss of heterozygosity on chromosome 9p13-23 in microdissected laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu X; An Q; Zhang J; Tang P; Cheng S
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 36(5):367-71. PubMed ID: 12761947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu XF; Tang PZ; Cheng SJ
    Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of tumor suppressor loci on chromosome 9 in primary human renal cell carcinomas.
    Cairns P; Tokino K; Eby Y; Sidransky D
    Cancer Res; 1995 Jan; 55(2):224-7. PubMed ID: 7812948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers.
    Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR
    Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of a novel tumor suppressor gene loci on chromosome 9p21-22 in oral cancer.
    Nakanishi H; Wang XL; Imai FL; Kato J; Shiiba M; Miya T; Imai Y; Tanzawa H
    Anticancer Res; 1999; 19(1A):29-34. PubMed ID: 10226521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
    Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
    J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detailed deletion mapping of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis.
    Xu XF; Gao YN; Cheng SJ
    Chin Med J (Engl); 2004 Aug; 117(8):1204-9. PubMed ID: 15361296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene.
    Wiest JS; Franklin WA; Otstot JT; Forbey K; Varella-Garcia M; Rao K; Drabkin H; Gemmill R; Ahrent S; Sidransky D; Saccomanno G; Fountain JW; Anderson MW
    Cancer Res; 1997 Jan; 57(1):1-6. PubMed ID: 8988029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Allele-specific chromosome 9p deletion in oral cancer].
    Xiao L; Ng IO; Luo ZC
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2001 Oct; 19(5):275-7. PubMed ID: 12539477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Loss of heterozygosity in the 9p21 region as an inactivation mechanism of the p16 suppressor gene].
    Maestro de las Casas ML; Sanz-Casla MT; del Barco V; Moreno J; Zanna I; Redondo E; Fernández C; Izquierdo L; Resel Estévez L
    Arch Esp Urol; 2000 Sep; 53(7):603-9. PubMed ID: 11037653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant p16 expression is correlated with hemizygous deletions at the 9p21-22 chromosome region in non-small cell lung carcinomas.
    Spanakis NE; Gorgoulis V; Mariatos G; Zacharatos P; Kotsinas A; Garinis G; Trigidou R; Karameris A; Tsimara-Papastamatiou H; Kouloukousa M; Manolis EN; Kittas C
    Anticancer Res; 1999; 19(3A):1893-9. PubMed ID: 10470133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High frequency of deletion on chromosome 9p21 may harbor several tumor-suppressor genes in human prostate cancer.
    Perinchery G; Bukurov N; Nakajima K; Chang J; Li LC; Dahiya R
    Int J Cancer; 1999 Nov; 83(5):610-4. PubMed ID: 10521795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent allele loss on 9p21-22 defines a smallest common region in the vicinity of the CDKN2 gene in sporadic breast cancer.
    An HX; Niederacher D; Picard F; van Roeyen C; Bender HG; Beckmann MW
    Genes Chromosomes Cancer; 1996 Sep; 17(1):14-20. PubMed ID: 8889502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High incidence of allelic loss on chromosome 5 and inactivation of p15INK4B and p16INK4A tumor suppressor genes in oxystress-induced renal cell carcinoma of rats.
    Tanaka T; Iwasa Y; Kondo S; Hiai H; Toyokuni S
    Oncogene; 1999 Jun; 18(25):3793-7. PubMed ID: 10391689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic loss at the D9S171 locus on chromosome 9p13 is associated with progression of papillary renal cell carcinoma.
    Schraml P; Müller D; Bednar R; Gasser T; Sauter G; Mihatsch MJ; Moch H
    J Pathol; 2000 Mar; 190(4):457-61. PubMed ID: 10699995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detailed deletion mapping on chromosome region 9p21 in human periampullary neoplasms.
    Wang C; Lu X; Liu G; Dai L; Xu T; Chen Y; Gao C; Wen X; Qian J
    Chin Med J (Engl); 2001 Jun; 114(6):588-91. PubMed ID: 11780432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
    Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
    Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer.
    Czerniak B; Chaturvedi V; Li L; Hodges S; Johnston D; Roy JY; Luthra R; Logothetis C; Von Eschenbach AC; Grossman HB; Benedict WF; Batsakis JG
    Oncogene; 1999 Feb; 18(5):1185-96. PubMed ID: 10022124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.